Want to see SE:GENI full AI Analyst Report?

Generic Sweden AB (GENI) Price & Analysis

2 Followers

GENI Stock Chart & Stats

kr46.45

-kr0.40(-0.70%)

At close: Mar 06 4:00 PM EST

kr46.45

-kr0.40(-0.70%)

Day’s Range― - ―

52-Week Rangekr33.50 - kr57.60

Previous CloseN/A

Volume12.15K

Average Volume (3M)20.09K

Market Cap

kr457.26M

Enterprise Valuekr368.32

Total Cash (Recent Filing)kr55.76M

Total Debt (Recent Filing)kr0.00

Price to Earnings (P/E)15.0

Beta0.47

Next Earnings

Aug 20, 2026

EPS Estimate

0.62

Next Dividend Ex-DateN/A

Dividend Yield3.48%

Share Statistics

EPS (TTM)2.52

Shares Outstanding12,292,020

10 Day Avg. Volume18,353

30 Day Avg. Volume20,086

Financial Highlights & Ratios

PEG Ratio1.31

Price to Book (P/B)8.56

Price to Sales (P/S)3.10

P/FCF Ratio14.63

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)2.71

Revenue Forecast (FY)kr196.00M

Bulls Say, Bears Say

Bulls Say

Balance Sheet StrengthThe company carries zero debt across reported periods and has steadily increased equity, materially lowering financial risk and improving capital resilience. A strong, debt-free balance sheet supports durable investment capacity, dividend policy flexibility, and downside protection over months.

High Profitability & GrowthVery strong trailing profitability combined with a sharp TTM revenue acceleration indicates scalable unit economics and effective pricing or product-market fit. Sustained margins near current levels underpin durable earnings generation and reinvestment ability if growth persists.

Cash Conversion QualityOperating cash flow exceeding net income and free cash flow close to earnings point to high earnings quality and reliable cash generation. This supports long-term funding of growth initiatives, dividends, or buybacks without relying on external financing.

Bears Say

Declining Gross MarginA multi-year decline in gross margin suggests rising delivery costs, pricing pressure, or adverse mix shifts. If persistent, this trend can compress operating margins and limit the company's ability to sustain current high profitability and reinvestment rates over the medium term.

Negative FCF GrowthA ~21% drop in free cash flow growth in the TTM window creates volatility in internal funding capacity. Lower FCF growth may force higher reinvestment pacing, tighten discretionary spending, or pressure dividends and share repurchases if the decline persists.

Elevated ROE May NormalizeExceptionally high ROE reflects strong current returns but increases the risk of mean reversion if margins or growth moderate. Reliance on transient advantages or favorable one-off items could lead to lower long-term return on equity and tempered investor expectations.

GENI FAQ

What was Generic Sweden AB’s price range in the past 12 months?

Generic Sweden AB lowest stock price was kr33.50 and its highest was kr57.60 in the past 12 months.

What is Generic Sweden AB’s market cap?

Generic Sweden AB’s market cap is kr457.26M.

When is Generic Sweden AB’s upcoming earnings report date?

Generic Sweden AB’s upcoming earnings report date is Aug 20, 2026 which is in 34 days.

How were Generic Sweden AB’s earnings last quarter?

Generic Sweden AB released its earnings results on May 13, 2026. The company reported kr0.63 earnings per share for the quarter, beating the consensus estimate of kr0.6 by kr0.03.

Is Generic Sweden AB overvalued?

According to Wall Street analysts Generic Sweden AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Generic Sweden AB pay dividends?

Generic Sweden AB pays a Annually dividend of kr1.75 which represents an annual dividend yield of 3.48%. See more information on Generic Sweden AB dividends here

What is Generic Sweden AB’s EPS estimate?

Generic Sweden AB’s EPS estimate is 0.62.

How many shares outstanding does Generic Sweden AB have?

Generic Sweden AB has 12,292,020 shares outstanding.

What happened to Generic Sweden AB’s price movement after its last earnings report?

Generic Sweden AB reported an EPS of kr0.63 in its last earnings report, beating expectations of kr0.6. Following the earnings report the stock price went up 12.061%.

Which hedge fund is a major shareholder of Generic Sweden AB?

Currently, no hedge funds are holding shares in SE:GENI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Generic Sweden AB

Operating as a technology firm, Generic Sweden AB delivers messaging functionalities compatible with any application. The company additionally furnishes a comprehensive platform dedicated to digital communication services. Established in 1993, its corporate headquarters are located in Stockholm, Sweden.